Cotton, S., Azevedo, R., Gaiteiro, C., Ferreira, D., Lima, L., Peixoto, A., . . . Ferreira, J. A. (2017). Targeted O‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours. Mol Oncol.
Chicago Style CitationCotton, Sofia, et al. "Targeted O‐glycoproteomics Explored Increased Sialylation and Identified MUC16 As a Poor Prognosis Biomarker in Advanced‐stage Bladder Tumours." Mol Oncol 2017.
MLA CitationCotton, Sofia, et al. "Targeted O‐glycoproteomics Explored Increased Sialylation and Identified MUC16 As a Poor Prognosis Biomarker in Advanced‐stage Bladder Tumours." Mol Oncol 2017.
Warning: These citations may not always be 100% accurate.